Sign In
Buy AMGN
$338.22
+9.96 (+3.03%)
At Close: Jun 03, 2026
AMGN Fairly Valued by DCF at $289
07:30am, Monday, 13'th Apr 2026
On April 13, 2026, we delve into the discounted cash flow (DCF) analysis for Amgen Inc (AMGN), a company that has shown a price performance of +28.6% over the p
Curtis Advisory Group LLC Makes New Investment in Amgen Inc. $AMGN
05:00am, Sunday, 12'th Apr 2026
Curtis Advisory Group LLC purchased a new position in Amgen Inc. (NASDAQ: AMGN) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The
Clarity Wealth Advisors LLC Invests $3.91 Million in Amgen Inc. $AMGN
05:22am, Saturday, 11'th Apr 2026
Clarity Wealth Advisors LLC purchased a new position in shares of Amgen Inc. (NASDAQ: AMGN) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 11,937 share
Why Amgen (AMGN) is Poised to Beat Earnings Estimates Again
01:11pm, Friday, 10'th Apr 2026
Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
AMGN Fairly Valued by DCF at $289
07:46am, Friday, 10'th Apr 2026
On April 10, 2026, we present a DCF analysis for Amgen Inc (AMGN), a company that has shown a price increase of 26.0% over the past year, despite a recent dip o
Encompass Wealth Advisors LLC Sells 3,010 Shares of Amgen Inc. $AMGN
04:36am, Friday, 10'th Apr 2026
Encompass Wealth Advisors LLC lowered its holdings in shares of Amgen Inc. (NASDAQ: AMGN) by 50.1% during the undefined quarter, according to the company in its most recent filing with the SEC. The fu
8,657 Shares in Amgen Inc. $AMGN Purchased by Flagship Capital Management Inc.
04:36am, Friday, 10'th Apr 2026
Flagship Capital Management Inc. acquired a new position in Amgen Inc. (NASDAQ: AMGN) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fir
Amgen's lung cancer drug tarlatamab wins China approval
04:10am, Friday, 10'th Apr 2026
Amgen's lung cancer drug tarlatamab has won approval from China's National Medical Products Administration, its development and commercialisation partner BeOne Medicines said on Friday on WeChat
Amgen (AMGN) Exceeds Market Returns: Some Facts to Consider
06:50pm, Thursday, 09'th Apr 2026
Amgen (AMGN) closed at $355.6 in the latest trading session, marking a +1.66% move from the prior day.
Eli Lilly Vs. Amgen: Who Leads Obesity And IMIDs
09:53am, Thursday, 09'th Apr 2026
Amgen Inc. and Eli Lilly and Company occupy leading positions in the immune-mediated inflammatory diseases treatment market. Moreover, AMGN hopes to grab a piece of the GLP-1s market from LLY. Each of
Amgen (AMGN) Beats Stock Market Upswing: What Investors Need to Know
07:00pm, Wednesday, 08'th Apr 2026
Amgen (AMGN) reached $349.81 at the closing of the latest trading day, reflecting a +2.89% change compared to its last close.
BIP Wealth LLC Acquires 8,785 Shares of Amgen Inc. $AMGN
05:10am, Wednesday, 08'th Apr 2026
BIP Wealth LLC raised its holdings in Amgen Inc. (NASDAQ: AMGN) by 808.2% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm ow
Amgen's Thyroid Eye Disease Data Rocks Rival Viridian, Makes It The Better Buy
12:03pm, Tuesday, 07'th Apr 2026
Amgen Inc. is rated a solid Buy, supported by robust revenue growth, pipeline strength, and recent FDA approvals despite looming patent expiries on legacy drugs. Tepezza's successful Phase 3 subcutane
Is Amgen (AMGN) Outperforming Other Medical Stocks This Year?
11:01am, Tuesday, 07'th Apr 2026
Here is how Amgen (AMGN) and BioAge Labs, Inc. (BIOA) have performed compared to their sector so far this year.
Here's Why Amgen (AMGN) is a Strong Value Stock
11:01am, Tuesday, 07'th Apr 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
